CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

BMEYE - Cardiovascular Intelligence

BMEYE - Cardiovascular Intelligence is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accent On Health At Latham Inc

Accent On Health At Latham Inc is a Latham, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NationsBenefits

NationsBenefits is a leading supplemental benefits company that guarantees cost savings and long-term health outcomes to managed care organizations and their members.

Circle Cardiovascular Imaging

Circle Cardiovascular Imaging is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

American Patient Transport Systems

American Patient Transport Systems Inc. is a Hazleton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.